Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 57.60M | € 61.30M | € 97.80M | € 60.80M | € 144.80M |
Total Assets | € 2.04B | € 1.95B | € 1.99B | € 1.97B | € 2.00B |
Total Debt | € 755.30M | € 667.60M | € 748.70M | € 736.90M | € 811.70M |
Net Debt | € 697.70M | € 606.30M | € 650.90M | € 676.10M | € 666.90M |
Total Liabilities | € 1.69B | € 1.61B | € 1.69B | € 1.73B | € 1.77B |
Stockholders Equity | € 338.90M | € 331.20M | € 286.80M | € 231.50M | € 225.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |